We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$313M
Cap. Flow
% of AUM
6.14%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.68% |
| 2 | Consumer Discretionary | 6.01% |
| 3 | Consumer Staples | 4.52% |
| 4 | Utilities | 3.94% |
| 5 | Industrials | 3.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$9B
| $33.3M | 0.65% |
836,400
+44,575
| +6% | +$1.59M |
|
27
Icon
ICLR
$13.9B
| $33.1M | 0.65% |
818,929
+285,630
| +54% | +$11.4M |
|
|
AMRI
28
DELISTED
Albany Molecular Research Inc
AMRI
| $31.8M | 0.62% |
3,150,000
+1,115,000
| +55% | +$13.5M |
|
|
ZGNX
29
DELISTED
Zogenix, Inc.
ZGNX
| $31.3M | 0.62% |
1,138,500
+926,000
| +436% | +$20.8M |
|
30
Herbalife
HLF
$1.28B
| $30.9M | 0.61% |
785,978
+23,258
| +3% | +$806K |
|
31
NextEra Energy
NEE
$186B
| $30.9M | 0.61% |
1,444,000
+227,320
| +19% | +$4.79M |
|
32
Liberty Media Series A
FWONA
$23.5B
| $29.4M | 0.58% |
1,131,046
+197,616
| +21% | +$5.24M |
|
33
Sempra
SRE
$58.6B
| $29.4M | 0.58% |
654,272
+242,974
| +59% | +$10.8M |
|
|
HOLX
34
DELISTED
Hologic
HOLX
| $29.2M | 0.57% |
1,306,000
+873,115
| +202% | +$19.3M |
|
35
Zimmer Biomet
ZBH
$18.7B
| $28.7M | 0.56% |
316,875
-224,083
| -41% | -$19.4M |
|
36
Merck
MRK
$324B
| $28.6M | 0.56% |
597,963
-13,136
| -2% | -$600K |
|
37
McKesson
MCK
$105B
| $27.8M | 0.55% |
172,325
+140,805
| +447% | +$21.6M |
|
38
Acadia Pharmaceuticals
ACAD
$4.49B
| $27.7M | 0.54% |
1,106,622
-140,587
| -11% | -$3.32M |
|
|
WMGI
39
DELISTED
Wright Medical Group Inc
WMGI
| $26.4M | 0.52% |
860,887
-5,113
| -0.6% | -$145K |
|
40
Tenet Healthcare
THC
$22.2B
| $25.4M | 0.5% |
603,600
-694,731
| -54% | -$30.2M |
|
41
American Electric Power
AEP
$71.3B
| $25.3M | 0.5% |
541,563
-37,714
| -7% | -$1.74M |
|
|
LVNTA
42
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $25M | 0.49% |
831,037
+676,833
| +439% | +$18.2M |
|
|
ESRX
43
DELISTED
Express Scripts Holding Company
ESRX
| $24.5M | 0.48% |
348,273
-559,752
| -62% | -$36.6M |
|
|
ARTC
44
DELISTED
ARTHROCARE CORP
ARTC
| $24.1M | 0.47% |
+600,000
| New | +$22.2M |
|
45
Boston Scientific
BSX
$68.9B
| $23.4M | 0.46% |
+1,945,161
| New | +$23M |
|
|
PPL
46
PPL Corp
PPL
$27.3B
| $22.3M | 0.44% |
797,382
+779,205
| +4,287% | +$22M |
|
|
ITMN
47
DELISTED
INTERMUNE INC
ITMN
| $21.6M | 0.42% |
1,467,952
-4,628
| -0.3% | -$63.9K |
|
|
SPNC
48
DELISTED
Spectranetics Corp
SPNC
| $21.6M | 0.42% |
863,000
+710,458
| +466% | +$15.2M |
|
|
BEAM
49
DELISTED
BEAM INC COM STK (DE)
BEAM
| $21.3M | 0.42% |
312,471
+76,003
| +32% | +$5.14M |
|
|
FLNA
50
Filana Therapeutics
FLNA
$42.3M
| $21.1M | 0.42% |
621,429
| – | – |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $313M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.